Active, Not Recruiting
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
NCT06178445
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
- Locations
-
- Universitätsklinikum Augsburg Augsburg, Germany
- Charité Universitätsmedizin Berlin, Germany
- Krankenhaus Nordwest (KHNW) Frankfurt, Germany
- Universitätsklinikum Freiburg Freiburg im Breisgau, Germany